Sunshine Biopharma (SBFM)

$1.12 0.00 (N/A)
Market Cap 561,000.00
Revenue (ttm) 36.31M
Net Income (ttm) -5.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -16.47%
Debt to Equity Ratio 0.00
Volume 126,100
Avg Vol 412,834
Day's Range N/A - N/A
Shares Out 501,000.00
Stochastic %K 19%
Beta 1.17
Analysts Sell
Price Target $56.00

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 954 330 0684
Address:
333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States
FatCatFenix
FatCatFenix Aug. 19 at 1:29 PM
$SBFM Oh Look.. another PR for another heavily available drug in Canada. They’d be lucky to capture 3% of that 2.1B Canadian Market. Factor in expenses and their tiny 3rd party slice of the pie and your not left with much. All this is… is a PUMP PR to move the ATM and Warrants.
0 · Reply
MrTicker
MrTicker Aug. 19 at 1:13 PM
$QTEX QTREX Quantum Announces A Patent-Pending Technology Achieved First Direct Conversion Of 3D-Printed Dielectric Material Into Electrically Conductive, Graphene-Like Carbon BENZINGA 8:12 AM ET 8/19/2026 $FMEY BRIEF-Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc REUTERS 8:02 AM ET 8/19/2026 $SBFM BRIEF-Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril REUTERS 8:04 AM ET 8/19/2026
0 · Reply
contra7
contra7 Aug. 19 at 1:05 PM
$SBFM Only the 6th high value high demand generic approved since 5/1 all with multibillion dollar global markets.
0 · Reply
hotslots
hotslots Aug. 19 at 12:37 PM
$SBFM more drugs more drugs
1 · Reply
2pumps1dump
2pumps1dump Aug. 19 at 12:36 PM
$SBFM sector valued at $26B in 2025, yes please! https://www.benzinga.com/news/health-care/26/08/61297933/exclusive-sunshine-biopharma-secures-canadian-approval-for-generic-hypertension-drug
0 · Reply
2pumps1dump
2pumps1dump Aug. 19 at 12:32 PM
$SBFM
0 · Reply
MrTicker
MrTicker Aug. 19 at 12:31 PM
$SBFM EXCLUSIVE: Sunshine Biopharma Receives Canadian Approval for Generic Enalapril for Hypertension in Four Dosage Strengths; Shipping To begin By Year-End 2026 BENZINGA 7:30 AM ET 8/19/2026
0 · Reply
ShangVXO
ShangVXO Aug. 19 at 8:09 AM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $SBFM & $INAB very interesting
0 · Reply
hotslots
hotslots Aug. 18 at 11:34 PM
$SBFM now that they have pumped this up to almost 4 million shares ill lower my expectations further to $8
1 · Reply
MB66
MB66 Aug. 18 at 6:44 PM
$SBFM but, but, but….. we’ve got amoxicillin!
1 · Reply
Latest News on SBFM
Sunshine Biopharma receives Canadian regulatory approval for Enalapril

2026-08-19T13:11:16.000Z - 1 hour ago

Sunshine Biopharma receives Canadian regulatory approval for Enalapril

Sunshine Biopharma launches generic amoxicillin formulation in Canada

2026-08-07T13:06:38.000Z - 12 days ago

Sunshine Biopharma launches generic amoxicillin formulation in Canada

Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market

Aug 7, 2026, 9:00 AM EDT - 12 days ago

Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market

Sunshine announces approval of generic Dienogest tablets for Canadian market

2026-08-04T13:16:02.000Z - 15 days ago

Sunshine announces approval of generic Dienogest tablets for Canadian market

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval

Aug 4, 2026, 9:00 AM EDT - 15 days ago

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval

Sunshine Biopharma announces approval of generic Ondansetron tablets

2026-07-28T12:21:42.000Z - 22 days ago

Sunshine Biopharma announces approval of generic Ondansetron tablets

Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting

Jul 28, 2026, 8:00 AM EDT - 22 days ago

Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting

Sunshine Biopharma announces publication of new results on MR1-114

2026-07-20T12:45:19.000Z - 4 weeks ago

Sunshine Biopharma announces publication of new results on MR1-114

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings

Jul 20, 2026, 8:30 AM EDT - 4 weeks ago

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings

Sunshine Biopharma receives Canadian approval for generic Arimidex

2026-06-25T12:20:47.000Z - 7 weeks ago

Sunshine Biopharma receives Canadian approval for generic Arimidex

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

Jun 25, 2026, 8:00 AM EDT - 7 weeks ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

Sunshine Biopharma announces Canadian approval for Rivaroxaban

2026-06-01T12:23:56.000Z - 2 months ago

Sunshine Biopharma announces Canadian approval for Rivaroxaban

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

R

Sunshine Biopharma Inc trading halted, news pending

2026-05-29T23:55:22.000Z - 2 months ago

Sunshine Biopharma Inc trading halted, news pending

Sunshine Biopharma issued U.S. patent for coronavirus treatment tech

2026-05-29T13:11:09.000Z - 2 months ago

Sunshine Biopharma issued U.S. patent for coronavirus treatment tech

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

May 29, 2026, 8:00 AM EDT - 2 months ago

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

Sunshine Biopharma announces 1-for-10 reverse split of its common stock

2026-05-28T14:49:55.000Z - 2 months ago

Sunshine Biopharma announces 1-for-10 reverse split of its common stock

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

May 28, 2026, 9:00 AM EDT - 2 months ago

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

Sunshine announces approval of generic amoxicillin formulation for Canada

2026-05-21T11:17:11.000Z - 3 months ago

Sunshine announces approval of generic amoxicillin formulation for Canada

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

May 21, 2026, 7:00 AM EDT - 3 months ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

3 Penny Stocks to Watch Now, 5/19/26

2026-05-19T16:21:43.000Z - 3 months ago

3 Penny Stocks to Watch Now, 5/19/26

AIIO GOVX

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 19, 2026, 12:05 PM EDT - 3 months ago

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

May 18, 2026, 12:15 PM EDT - 3 months ago

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?

2026-05-18T12:55:34.000Z - 3 months ago

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?

Sunshine Biopharma files to sell 5.825M common units

2026-05-12T21:20:04.000Z - 3 months ago

Sunshine Biopharma files to sell 5.825M common units

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

2026-04-06T12:53:12.000Z - 4 months ago

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

2026-04-06T12:52:43.000Z - 4 months ago

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Apr 6, 2026, 8:30 AM EDT - 4 months ago

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Oct 28, 2025, 2:10 PM EDT - 10 months ago

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Sunshine Biopharma’s Nora Pharma receives Health Canada approval for domperidone

2025-10-28T11:50:45.000Z - 10 months ago

Sunshine Biopharma’s Nora Pharma receives Health Canada approval for domperidone

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Oct 28, 2025, 7:45 AM EDT - 10 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Sunshine Biopharma announces commercial launch of doxycycline in Canada

2025-10-20T11:50:37.000Z - 10 months ago

Sunshine Biopharma announces commercial launch of doxycycline in Canada

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Oct 20, 2025, 7:45 AM EDT - 10 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 16, 2025, 7:45 AM EDT - 10 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 10:45 AM EDT - 11 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Oct 14, 2025, 8:50 AM EDT - 11 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Oct 14, 2025, 7:00 AM EDT - 11 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Oct 9, 2025, 8:00 AM EDT - 11 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jul 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 15, 2025, 4:15 PM EDT - 1 year ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

May 6, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 21, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

FatCatFenix
FatCatFenix Aug. 19 at 1:29 PM
$SBFM Oh Look.. another PR for another heavily available drug in Canada. They’d be lucky to capture 3% of that 2.1B Canadian Market. Factor in expenses and their tiny 3rd party slice of the pie and your not left with much. All this is… is a PUMP PR to move the ATM and Warrants.
0 · Reply
MrTicker
MrTicker Aug. 19 at 1:13 PM
$QTEX QTREX Quantum Announces A Patent-Pending Technology Achieved First Direct Conversion Of 3D-Printed Dielectric Material Into Electrically Conductive, Graphene-Like Carbon BENZINGA 8:12 AM ET 8/19/2026 $FMEY BRIEF-Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc REUTERS 8:02 AM ET 8/19/2026 $SBFM BRIEF-Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril REUTERS 8:04 AM ET 8/19/2026
0 · Reply
contra7
contra7 Aug. 19 at 1:05 PM
$SBFM Only the 6th high value high demand generic approved since 5/1 all with multibillion dollar global markets.
0 · Reply
hotslots
hotslots Aug. 19 at 12:37 PM
$SBFM more drugs more drugs
1 · Reply
2pumps1dump
2pumps1dump Aug. 19 at 12:36 PM
$SBFM sector valued at $26B in 2025, yes please! https://www.benzinga.com/news/health-care/26/08/61297933/exclusive-sunshine-biopharma-secures-canadian-approval-for-generic-hypertension-drug
0 · Reply
2pumps1dump
2pumps1dump Aug. 19 at 12:32 PM
$SBFM
0 · Reply
MrTicker
MrTicker Aug. 19 at 12:31 PM
$SBFM EXCLUSIVE: Sunshine Biopharma Receives Canadian Approval for Generic Enalapril for Hypertension in Four Dosage Strengths; Shipping To begin By Year-End 2026 BENZINGA 7:30 AM ET 8/19/2026
0 · Reply
ShangVXO
ShangVXO Aug. 19 at 8:09 AM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $SBFM & $INAB very interesting
0 · Reply
hotslots
hotslots Aug. 18 at 11:34 PM
$SBFM now that they have pumped this up to almost 4 million shares ill lower my expectations further to $8
1 · Reply
MB66
MB66 Aug. 18 at 6:44 PM
$SBFM but, but, but….. we’ve got amoxicillin!
1 · Reply
spaarrow1
spaarrow1 Aug. 18 at 8:30 AM
$SBFM guys. Have u heard about the stock Cidara Thera
0 · Reply
contra7
contra7 Aug. 17 at 10:41 PM
$SBFM
1 · Reply
hotslots
hotslots Aug. 17 at 5:26 PM
$SBFM strategically heading under $1.X for next RS
2 · Reply
FatCatFenix
FatCatFenix Aug. 17 at 5:24 PM
$SBFM DANG 1.03$ - Guess those warrants got repriced. Whats next… REVERSE SPLIT! Looks like ALL my predictions were spot on! So were those of the select few here who’ve been warning y’all. Never listen to the moron yelling BUYOUT 😂
0 · Reply
hotslots
hotslots Aug. 15 at 2:55 AM
$SBFM what a dogshit group. How can sales be less with all these additional drugs to sell haha! They should just sell the inventory off and give us 3 bucks per share. Dogshit
2 · Reply
contra7
contra7 Aug. 15 at 1:46 AM
$SBFM
0 · Reply
Masterrunner
Masterrunner Aug. 14 at 8:13 PM
$SBFM Meanwhile in Nora's warehouse 😂
0 · Reply
FatCatFenix
FatCatFenix Aug. 14 at 2:45 PM
$SBFM SBFM Aug. 13 10-Q — just the numbers: • $13.75M cash as of June 30 • $17.35M H1 revenue • -$2.81M H1 net loss • 26.2% Q2 gross margin vs. 36.4% Q2 2025 (10.2% Less) • Common shares: 2.28M → 3.88M • +1.60M shares / +70% • 1.43M shares sold through the ATM from July 27–Aug. 12, generating $1.72M net Warrants — before → after: • Series B: 12.98M @ $2.3949 → 25.48M @ $1.2202 • Series C: 2.02M @ $5.00 → 4.04M @ $2.50 That’s ~29.5M B+C warrants against ~3.9M common shares outstanding. The filing says the B warrants remain subject to further adjustment as more of the ATM is sold. All Normal Here! 🤣 Having fun yet @contra7 🤪
2 · Reply
KeailiIlani4U
KeailiIlani4U Aug. 14 at 8:33 AM
$SBFM 2nd quarter revenue down again, outstanding shares count up, am thinking this is not going to be my year!
0 · Reply
RunForFun
RunForFun Aug. 14 at 3:04 AM
$SBFM This is a POS. I have 5 shares! I had hundreds of thousands before. The constant reverse splits cost me over $20,000. Lesson be learned.
0 · Reply
Masterrunner
Masterrunner Aug. 13 at 2:22 PM
$SBFM The Aegis/Sleezyballs playbook has been very consistent through the years. Pump will happen, when it does. Get the F out! NFA GLTA
0 · Reply
Masterrunner
Masterrunner Aug. 13 at 1:11 PM
$SBFM Trending
0 · Reply